Radiobiological indices that consider volume: A review

Australasian Physical and Engineering Sciences in Medicine

Volumn 25, Issue 2, 2002, Pages 47-57

  Holloway, Lois ^a   Hoban, P ^a   Metcalfe, P ^a  

^a LIVERPOOL HOSPITAL   (Australia)

Author keywords

Normal tissue complication probability; Radiobiological modelling; Review; Tumour control probability; Volume

Indexed keywords

CELLS; CORRELATION METHODS; FRACTIONATION; MATHEMATICAL MODELS; PATIENT TREATMENT; PROBABILITY; TUMORS;

RADIOBIOLOGICAL INDICES;

RADIOTHERAPY;

ACCURACY; CALCULATION; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL PRACTICE; CORRELATION ANALYSIS; DATA BASE; DOSE CALCULATION; HISTOGRAM; HUMAN; MATHEMATICAL ANALYSIS; MODEL; PROBABILITY; RADIATION DOSE FRACTIONATION; RADIOBIOLOGY; REVIEW; TISSUE INJURY; TREATMENT PLANNING; TUMOR; TUMOR VOLUME;

EID: 0036652484     PISSN: 01589938     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03178466     Document Type: Review

References (68)

1. The use of the linear quadratic model in radiotherapy: A review
2. Dose, volume, and tumor-control predictions in radiotherapy
3. The linear-quadratic transformation of dose - Volume histograms in fractionated radiotherapy
4. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses
5. Dose-volume histograms for bladder and rectum
6. Med dose wall histograms for the rectum
7. Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose- surface histograms
8. Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy
9. Incorporation of functional status into dose-volume analysis
10. Treatment plan evaluation using dose-volume histogram (DVH) and spatial dose-volume histogram (zDVH)
11. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method
12. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations
13. Tolerance of normal tissue to therapeutic irradiation
14. Reporting and analyzing dose distributions: A concept of equivalent uniform dose
15. A generalized concept of Equivalent Uniform Dose (EUD)
16. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis
17. Normal tissue complication probabilities: How well do the models work?
18. Some implications of the linear quadratic model for tumor control probability
19. Optimization of uncomplicated control for head and neck tumors
20. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density
21. Optimum parameters in a model for tumour control probability including interpatient heterogeneity
22. Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor
23. A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity
24. Predicting the radiation control probability of heterogeneous tumour ensembles: Data analysis and parameter estimation using a closed-form expression
25. Some characteristics of tumour control probability for heterogeneous tumours
26. Quantifying the effect of dose inhomogeneity in brachytherapy: Application to permanent prostatic implant with 125I seeds
27. The slope of the sigmoid dose response curve for tumor control
28. Steepness of the dose-response curve as a function of volume in an experimental tumor irradiated under ambient or hypoxic conditions
29. Why the utility of a normalized dose-response gradient (γ-factor) should be redefined
30. Viability of the EUD and TCP concepts as reliable dose indicators
31. The delta-TCP concept: A clinically useful measure of tumor control probability
32. Complication probability as assessed from dose-volume histograms
33. Dose-volume complication analysis for visual pathway structures of patients with advanced paranasal sinus tumors
34. Fraction size and dose parameters related to the incidence of pericardial effusions
35. Radiotoxic model for three-dimensional treatment planning. Part 1: Theoretical basis
36. Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation
37. Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation
38. Modeling of normal tissue response to radiation: The critical volume model
39. Normal tissue complication probabilities: Variable dose per fraction
40. Tumour and normal tissue responses to fractionated non-uniform dose delivery
41. Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture
42. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis
43. Estimation of the spatial distribution of target cells for radiation pneumonitis in mouse lung
44. The radiation response of the cervical spinal cord of the pig: Effects of changing the irradiated volume
45. Practical considerations in using calculated healthy-tissue complication probabilities for treatment-plan optimisation
46. Specification of the dose to organs at risk in external beam radiotherapy
47. State-of-the-art of external photon beam radiation treatment planning
48. Models in radiotherapy: Volume effects
49. Models in radiotherapy: Definition of decision criteria
50. Evaluation of high energy photon external beam treatment planning: Project summary. Photon Treatment Planning Collaborative Working Group
51. Isodose versus isoeffect in radiotherapy planning as applied to parallel opposed fields
52. Biologically effective dose distribution based on the linear quadratic model and its clinical relevance
53. Modelling the optimal radiotherapy regime for the control of T2 laryngeal carcinoma using parameters derived from several datasets
54. Clinical radiobiology of glottic T1 squamous cell carcinoma
55. Clinical radiobiology of malignant melanoma
56. Comparison of radiosurgery treatment modalities based on complication and control probabilities
57. Evaluation of linear accelerator radiosurgical techniques using biophysical parameters (NTCP and TCP)
58. An integrated logistic formula for prediction of complications for radiosurgery
59. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients
60. Physical and biological predictors of changes in whole-lung function following thoracic irradiation
61. External beam radiotherapy of localized prostatic adenocarcinoma. Evaluation of conformal therapy, field number and target margins
62. Comparison of treatment techniques for conformal radiotherapy of the prostate using dose-volume histograms and normal tissue complication probabilities
63. A comparison of conventional 'forward planning' with inverse planning for 3D conformal radiotherapy of the prostate
64. A method of analyzing rectal surface area irradiated and rectal complications in prostate conformal radiotherapy